FDA Inspection 1250072 — Fenwal International, Inc.

Fenwal International, Inc. — FEI 2627511

The FDA completed an inspection of Fenwal International, Inc. on September 18, 2024 in Maricao, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 7 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 18, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Maricao, PR (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
194221 CFR 211.180(e)Records reviewed annually
354721 CFR 211.46(b)Equipment for Environmental Control
355721 CFR 211.52Washing and toilet facilities are deficient
356521 CFR 211.58Buildings not maintained in good state of repair
360321 CFR 211.160(b)Scientifically sound laboratory controls